Skip to content
DataLookout
Menu

NCT07563192

Evaluation of the Effect of Smoking on Pyroptosis in Periodontal Pathogenesis

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 14 words
    • Trial completed
    • Secondary endpoints: details revised at 3 of 3 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Relative mRNA expression levels of TLR1,TLR4 and TLR6
Timeframe: Baseline (At the clinical examination)
Protein concerntrations of NLRP3, IL-18 and IL-1β
Timeframe: Baseline (At the time of clinical examinat

Secondary (3)

Periodontal Inflamed Surface Area (PISA)
Periodontal Clinical Measurements (PD and CAL)
Periodontal Indices (PI and GI)

Arms and interventions

Healthy Non-Smoker

Systemically healty individulas with clinically healthy periodontal tissues who have never smoked or have not smoked for least 5 years.

Gingivitis Non-Smoker

Systemically healty individulas diagnosed with gingivitis who are non-smokers.

Periodontitis Non-Smoker

Systemically healty individulas diagnosed with Stage III or IV periodontitis who are non-smokers.

Healthy Smoker

Systemically healty individulas with clinically healthy periodontal tissues who have been smoking least 10 cigarettes per day for at least 1 year.

Gingivitis Smoker

Systemically healty individulas with gingivitis who have been smoking least 10 cigarettes per day for at least 1 year.

Periodontitis Smoker

Systemically healty individulas diagnosed with Stage III or IV periodontitis who who have been smoking least 10 cigarettes per day for at least 1 year.

Sites

1 site in 1 country

  • Suleyman Demirel University, Faculty of Dentistry, Department of PeriodontologyIsparta, Isparta, Turkey (Türkiye)